Breaking Down the Canadian Proactive Cohort for People Living with MS (CanProCo)
Part I: Heidi’s journey with MS Having had multiple sclerosis (MS) for over 18 years, I feel like I’ve experienced every documented and…
Understanding the Canadian Proactive Cohort Study for People Living with MS: a conversation with Dr. Jiwon Oh
As one of the leading MS researchers in the country, researcher and clinician Dr. Jiwon Oh is ambitious to say the least. In…
Happy Holidays from the research team! Here is the research recap for 2018 and what we can hope for the future.
As the end of 2018 is right around the corner, I’m so excited by the progress made in the last year and what…
Understanding what it means to run a “cohort”
The term “cohort” is one that has been used a lot recently. You may have read the MS Update, news release, or the…
The faces behind the research team establishing the Canadian Proactive Cohort Study for People Living with MS (CanProCo)
Recruitment of 1,000 people with multiple sclerosis, and development of a holistic picture of the factors and interactions that lead to progression in…
ECTRIMS 2018: Updates on Progressive MS
Which subgroups of progressive MS should be treated? Dr. Xavier Montalban, professor at the University of Toronto, presented an overview of treatments in…
ECTRIMS 2018: Catching up with the MS-Society funded collaborative team that is working to improve cognition in people with progressive MS
The Multiple Sclerosis Society of Canada announced last month a $5 million grant in support of the first, international, multicenter clinical trial to investigate cognitive…
ECTRIMS 2018: Risk Factors for multiple sclerosis (MS)
Overview of the growing list of potential risk factors for MS Dr. Ali Manouchehrinia, Assistant Professor at the Karolinska Institutet, presented an overview…
